.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Identify first generic entrants

► See Plans & Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Cerilliant
QuintilesIMS
Mallinckrodt
US Department of Justice
Deloitte
Baxter
Boehringer Ingelheim
Harvard Business School
Teva

Pharmaceutical companies with the most 'Antibiotic GAIN Act' drugs

This chart shows the companies which have received the most GAIN Act exclusivities in the past five years.

The Generating Antibiotic Incentives Now Act provides for five years of market exclusivity for qualifying drugs.

The law defines qualifying drugs as 'an antibacterial or antifungal drug for human use intended to treat serious or life-threatening infections.'

Unlike most other regulatory extensions, which provide exclusivity starting from a drug's approval date, GAIN Act exclusivity provides an additional five years on top of any Hatch-Waxman exclusivity — even pediatric exclusivity, which extends an additional six months beyond patent protection.

The companies with the GAIN Act exclusivities are:

Back to Pharmaceutical Industry Infographics

For more information try a trial or see the database preview and plans and pricing

botpot